Navigation Links
Biotech firm has strokes, Alzheimer's in its sights

Madison, Wis. - While much of the attention paid to Quincy Bioscience centers on the compound it is developing from jellyfish, it is the company's emerging business model that may put other medical treatments 25,000 leagues under the sea.

Quincy Bioscience is based in Madison's University Research Park, but it derives its research supp......

Full article >>> ept/Psychology/faculty/moyer.html">James Moyer, said lab results thus far indicate the protein, aequorin, is much more "neuroprotective" than existing treatments. According to Underwood, aequorin has helped anywhere from 28 to 45 percent of brain cells survive, without toxicity, after being subjected to the lab equivalent of a stroke.

Ninety-nine percent of the body's calcium is conta......

Full article >>> sing the role future funding will play.

The company expects to have a pharmaceutical product on the market in seven years. It will seek to raise private equity to develop aequorin-based therapies for each disease it targets, starting with strokes and followed (not necessarily in this order) by Alzheimer's, Parkinson's, Huntington's, and Amyotrophic Lateral Sclerosis (ALS), also known as ......

Full article >>> property portfolio.

IQ visions

Quincy's science and the business model may take it farther than most biotechs, but it's the Milwaukee-Madison connection that intrigues Leonhart and others that envision a robust IQ Corridor. "It kind of shows that the research in this state can be created anywhere and be successfully planted elsewhere," he said.

......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 08/31/06


Related biology technology :

1. Biotech officials praise focus of new venture fund
2. Biotech executive books a career flight thats closer to home
3. Gala Biotech among companies sold for $3.3 billion
4. Biotech with Madison ties raises $21M in capital
5. Biotech firm uses live heart tissue in drug screens
6. Biotech talent drew venture-funded firm to Madison
7. 42 days until the 2006 Olympics of Biotechnology in Chicago
8. Biotech crops gaining acceptance, but their full promise has yet to be fulfilled
9. Biotech leads list of top U.S. companies to work for
10. Biotech flourishes in 2005 while Big Pharma is on the decline
11. Though Weakening, Biotech IPO Market Still Viable, Burril & Co. Says
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/20/2017)... ... February 20, 2017 , ... ... telemedicine company announces at HIMSS 2017 Annual Conference (Orlando, FL) a world-wide ... via a global cloud-based sharing and collaboration platform as part of the ...
(Date:2/20/2017)... ... February 20, 2017 , ... PuraCath Medical, an emerging company ... announced today that it has published the result of its recent research on ... (PDI), the official Journal of the International Society for Peritoneal Dialysis . ...
(Date:2/20/2017)... Fla. , Feb. 20, 2017  At ... conference in Orlando , IBM ... offerings, collaborators and clients. IBM Chairman, President and ... HIMSS17 opening keynote address today from 8:30-10 am ... www.ibm.com/watson/health , and ibm.com/industries/healthcare. Her remarks examine the ...
(Date:2/19/2017)... ... 19, 2017 , ... Expanding Portfolio to Include Lab Equipment ... with the goal of expanding the reach of its quality and precision to ... analysis meters were introduced into the market in 2014. , The OHAUS Starter ...
Breaking Biology Technology:
(Date:2/21/2017)... Der weltweite Biobanking-Sektor wird bis zum Jahr 2018 ... mehr als 50 Vertretern aus verschiedenen Branchen wurde aber klar, ... Prognose zu realisieren. ... Zu den Schwierigkeiten für Biobanking-Profis ... die Biobank, die Implementierung Zeit sparender Technologien, ein besseres ...
(Date:2/13/2017)... , Feb. 13, 2017 Former 9/11 Commission ... Judiciary Committee, Janice Kephart of Identity Strategy ... Donald Trump,s "Executive Order: Protecting the Nation ... 27, 2017):  "As President Trump,s ,Travel Ban, ... has now essentially banned the travel ban, it is ...
(Date:2/8/2017)... Feb. 7, 2017  Aware, Inc. (NASDAQ: AWRE ... reported financial results for its quarter and year ended December ... of 2016 was $3.9 million compared to $6.9 million in ... quarter of 2016 was $0.6 million compared to $2.6 million ... fourth quarter of 2016 was $0.5 million, or $0.02 per ...
Breaking Biology News(10 mins):